ketoconazole has been researched along with tamsulosin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mattheus, M; Mehlburger, L; Michel, MC; Tatami, S; Troost, J; Tsuda, Y; Wein, M | 1 |
| El-Gamal, OM; Elbendary, M; Soliman, MG; Taha, MR; Tawfik, A | 1 |
| Allenet, B; Bedouch, P; Bensalah, N; Charpiat, B; Conort, O; Garcia, S; Juste, M; Rose, FX; Roubille, R; Tod, M | 1 |
2 review(s) available for ketoconazole and tamsulosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[How to act when an alpha-blocker is associated with a potent inhibitor of CYP3A4].
Topics: Adrenergic alpha-Antagonists; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; France; Government Agencies; Humans; Indoles; Ketoconazole; Quinazolines; Sulfonamides; Tamsulosin | 2017 |
2 trial(s) available for ketoconazole and tamsulosin
| Article | Year |
|---|---|
Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.
Topics: 14-alpha Demethylase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adult; Analysis of Variance; Area Under Curve; Cardiovascular System; Cross-Over Studies; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Drug Interactions; Half-Life; Heart; Humans; Ketoconazole; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Tamsulosin; Young Adult | 2011 |
Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Ketoconazole; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention | 2013 |
2 other study(ies) available for ketoconazole and tamsulosin
| Article | Year |
|---|---|
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |